home / stock / atrc / atrc news

ATRC News and Press, AtriCure Inc. From 05/15/24

Stock Information
Company Name: AtriCure Inc.
Stock Symbol: ATRC
Market: NASDAQ
Website: atricure.com
Menu
ATRC ATRC Quote ATRC Short ATRC News ATRC Articles ATRC Message Board
Get ATRC Alerts

News, Short Squeeze, Breakout and More Instantly...
ATRC - AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Leerink Partners Healt...
ATRC - CytomX Therapeutics, Allarity Therapeutics, Pulmonx among healthcare movers

2024-05-02 10:00:43 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...

ATRC - US Companies Moving the Markets, Morning edition
Thu, May 02, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...

ATRC - AtriCure, Inc. (ATRC) Q1 2024 Earnings Call Transcript

2024-05-02 01:48:02 ET AtriCure, Inc. (ATRC) Q1 2024 Earnings Conference Call May 1, 2024 16:30 ET Company Participants Marissa Bych - Investor Relations Mike Carrel - President and Chief Executive Officer Angie Wirick - Chief Financial Officer Conference C...
ATRC - AtriCure Non-GAAP EPS of -$0.25 misses by $0.02, revenue of $108.9M beats by $2M

2024-05-01 16:27:26 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure Q1 2024 Earnings Preview AtriCure upgraded at Oppenheimer on valuation Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for...

ATRC - AtriCure Reports First Quarter 2024 Financial Results

Worldwide revenue of $108.9 million – an increase of 16.4% year over year AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, t...

ATRC - Expected US Company Earnings on Wednesday, May 1st, 2024

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
ATRC - AtriCure Q1 2024 Earnings Preview

2024-04-30 17:35:59 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure upgraded at Oppenheimer on valuation AtriCure Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for...

ATRC - AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Bank of America Securi...

ATRC - AtriCure upgraded at Oppenheimer on valuation

2024-04-23 08:34:50 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2023 Earnings Call Transcript AtriCure Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on AtriCure Historical earnings data for AtriCure Financial information for AtriCure ...
Previous 10 Next 10